Trial
NCT00947011
Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Merck Sharp & Dohme LLC
Condition
Glucose Homeostasis
Intervention
Placebo
Why stopped
PI left JHU
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-12